RARA and ductal breast carcinoma in situ: Based on the common protein signature of HME1”DCIS-precursor” cell lines with mutations that affect RA-RARA signaling, we identified by a stepwise approach (Figure 1) a set of protein-miRNA pairs, including ANXA8-miRNA pairs.